Development Of The Listening In Spatialized Noise - Tonal Test (or LiSN-T)
Funder
National Health and Medical Research Council
Funding Amount
$227,136.00
Summary
In this project a novel listening test software will be developed for diagnosing spatial processing disorder in children. These children often have difficulties in understanding teachers in classrooms, which can significantly impact their ability to learn. The developed software will be specifically designed for diagnosing 5-year old children, before they enter primary school, and in contrast to existing tests will be independent of their language background.
Novel Therapy For Enhancing Organ Maturation In Pre-term Babies
Funder
National Health and Medical Research Council
Funding Amount
$694,323.00
Summary
This project is developing a factor to enhance organ maturation and repair that may provide a new therapy for premature babies and fetuses with birth defects. This exciting new finding allows for the development of treatments of underdeveloped organs, in particular the lungs of premature and growth restricted babies. We are also trialing this factor in unborn babies with defects to the kidneys and lungs of which there is currently no cure.
Low Cost Smart Screening System For Sight Threatening Eye Disease: Diabetic Retinopathy
Funder
National Health and Medical Research Council
Funding Amount
$529,079.00
Summary
The aim of the project is to develop an automated disease grading and clinical decision support system for diabetic retinopathy (DR) to perform eye screening by primary care providers and nurses. The grading system will automatically extract DR pathology from a patient’s color fundus images by image processing, feature detection and machine learning algorithms. Based on the detected information, the system can classify the patient as non symptom or a specific disease level.
Development Of A Non-invasive Magnetic Resonance Based Cartilage Damage Assessment Technique
Funder
National Health and Medical Research Council
Funding Amount
$556,131.00
Summary
This project will develop automated methods for the extraction of 3D maps of cartilage, bone and other anatomy from high field Magnetic Resonance Images of joints in the body.
MR Hip Intervention And Planning System To Enhance Clinical And Surgical Outcomes
Funder
National Health and Medical Research Council
Funding Amount
$668,069.00
Summary
Degenerative hip disorders and osteoarthritis are a major cause of chronic pain and disability. This project will develop a software tool that allows clinicians to assess, monitor and plan patient treatment using magnetic resonance imaging. It will be the first tool that models joint motion using assessments of bone, cartilage and labral tissue. This will help guide treatment selection and improve outcomes from hip surgeries performed on over 20,000 Australians each year.
PEERS: Developing An IPad-delivered Social Assessment Tool For Children And Adolescents
Funder
National Health and Medical Research Council
Funding Amount
$898,094.00
Summary
We will produce a tool to identify social impairments in children and adolescents. The tool, called PEERSTM (Paediatric Evaluation of Emotions, Relationships & Socialisation), is at the forefront of digital health, combining cutting edge research with technology for increased accuracy, speed and efficiencies within the healthcare system. It is: i) based on social neuroscience theory; ii) supported by poof-of-concept data; and iii) of high relevance to health professionals and educators.
Sensitizing Tumours To Immunotherapy: Development Of An RNA-based Therapeutic For Pancreatic Adenocarcinoma That Targets The Immunosuppressive Tumour Microenvironment.
Funder
National Health and Medical Research Council
Funding Amount
$192,347.00
Summary
The blood vessels of tumours are highly abnormal resulting in leakiness and hypoxia within the microenvironment. These abnormalities contribute both to the pathology and also to resistance to treatment. We have developed a new drug that is able to inhibit vascular leak, better the response to therapies and improve disease outcome. This work will generate essential data for the development of this drug towards Clinical Trials through interaction with International Pharma.
Development Of A Safe Live Genetically Attenuated Blood Stage Malaria Vaccine
Funder
National Health and Medical Research Council
Funding Amount
$822,191.00
Summary
Malaria presents an enormous global health problem, and also has a significant impact on social and economic development in countries where the disease is endemic. Our project will produce a live genetically-modified vaccine against Plasmodium falciparum, the parasite that causes the form of malaria mostly deadly to humans. Our development plan will include the first ever clinical trials of a malaria vaccine of this kind and will look at vaccine safety and effectiveness.
Optimisation Of A Potent And Fast Acting Antimalarial Class That Is Orally Efficacious In Vivo
Funder
National Health and Medical Research Council
Funding Amount
$683,916.00
Summary
Malaria is a devastating disease that results in 600 000 deaths annually. Current therapeutics used to combat malaria have a limited duration of use in the clinic due to the onset of resistance. We have identified a highly active antimalarial series that we propose to further develop to meet the prerequisites required for partnership with the Medicines for Malaria Venture (MMV) for progression into the clinic.
OctapeptinX Potentiators To Treat XDR Gram-negative Infections
Funder
National Health and Medical Research Council
Funding Amount
$1,377,149.00
Summary
There is an urgent need for the development of new antibiotics to treat drug-resistant infections, with the World Health Organisation and other agencies warning of a critical threat to human health. Potentiators are drugs that help obsolete antibiotics regain activity against resistant bacteria. We aim to develop a novel class of potentiators, the octapeptins, to resurrect the activity of old antibiotics so they can be used to treat infections caused by highly-resistant Gram-negative bacteria.